[{"id":"9b8f0668-89c2-4a17-b398-80a6f02ea55e","acronym":"","url":"https://clinicaltrials.gov/study/NCT01865045","created_at":"2021-01-18T08:20:35.723Z","updated_at":"2024-07-02T16:36:04.175Z","phase":"","brief_title":"Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients","source_id_and_acronym":"NCT01865045","lead_sponsor":"Armando Santoro, MD","biomarkers":" BRCA1 • TUBB3","pipe":" | ","alterations":" BRCA1 expression • TUBB3 expression","tags":["BRCA1 • TUBB3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA1 expression • TUBB3 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e vinorelbine tartrate"],"overall_status":"Completed","enrollment":" Enrollment 150","initiation":"Initiation: 11/01/2012","start_date":" 11/01/2012","primary_txt":" Primary completion: 12/01/2016","primary_completion_date":" 12/01/2016","study_txt":" Completion: 12/01/2017","study_completion_date":" 12/01/2017","last_update_posted":"2022-09-10"}]